Literature DB >> 16081946

Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.

Asmaa Al Mosaid1, Derek J Sullivan, Itzhack Polacheck, Faisal A Shaheen, Osama Soliman, Saleh Al Hedaithy, Sahar Al Thawad, Motaz Kabadaya, David C Coleman.   

Abstract

DNA fingerprinting of Candida dubliniensis isolates using the species-specific probe Cd25 previously showed that this species consists of two distinct groups, termed Cd25 group I and Cd25 group II. The present study investigated the population structure of 30 C. dubliniensis oral isolates from Saudi Arabia and Egypt using Cd25 fingerprinting and rRNA gene internal transcribed spacer region-based genotyping. Cd25 fingerprinting analysis of these isolates revealed two distinct populations, the first of which consisted of 10 closely related genotype 1 isolates (average similarity coefficient [S(AB)] value, 0.86). The second population of 20 isolates was much more heterogeneous (average S(AB) value, 0.35) and consisted of two distinct subpopulations, one of which consisted of genotype 3 isolates (n = 13) and the other of genotype 4 isolates (n = 7). A mixed dendrogram generated from the fingerprint data from the 30 Saudi Arabian and Egyptian isolates, 5 Israeli isolates, and 51 previously characterized international isolates (32 of Cd25 group I and 19 of Cd25 group II) revealed the presence of three distinct main clades. The first corresponded to the previously described Cd25 group I and contained all the Saudi Arabian, Egyptian, and Israeli genotype 1 isolates mixed with international isolates. The second clade corresponded to the previously described Cd25 group II and contained three Israeli isolates, one genotype 2 isolate, one genotype 3 isolate, and a genotype 4 variant isolate, which were mixed with international isolates. The third clade has not been described before and consisted solely of the 20 Saudi Arabian and Egyptian genotype 3 and 4 isolates identified in this study and a previously described genotype 4 Israeli isolate. All 20 Cd25 group III isolates exhibited high-level resistance to 5-flucytosine (MIC > or = 128 microg/ml), whereas all Cd25 group I and Cd25 group II isolates tested (10 Saudi Arabian and Egyptian, 16 Israeli, and 24 international) were susceptible to 5-flucytosine (MIC < or = 0.125 microg/ml). The results of this study show for the first time the presence of a novel 5-flucytosine-resistant clade of C. dubliniensis (Cd25 group III) that is predominant among isolates from Saudi Arabia and Egypt and absent from a previously characterized international collection of 98 isolates from 15 countries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081946      PMCID: PMC1233943          DOI: 10.1128/JCM.43.8.4026-4036.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  [Genotypes of Candida dubliniensis in clinical isolates].

Authors:  Sonia Brena; María del Carmen Rubio; Ricardo Salesa; Isabel Iglesias; Joaquina Gil; Antonio Rezusta; María Dolores Moragues; José Pontón
Journal:  Rev Iberoam Micol       Date:  2004-03       Impact factor: 1.044

Review 2.  Candidiasis: the emergence of a novel species, Candida dubliniensis.

Authors:  D C Coleman; D J Sullivan; D E Bennett; G P Moran; H J Barry; D B Shanley
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

3.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

4.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.

Authors:  G P Moran; D J Sullivan; M C Henman; C E McCreary; B J Harrington; D B Shanley; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals.

Authors:  D Sullivan; K Haynes; J Bille; P Boerlin; L Rodero; S Lloyd; M Henman; D Coleman
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients.

Authors:  D Coleman; D Sullivan; B Harrington; K Haynes; M Henman; D Shanley; D Bennett; G Moran; C McCreary; L O'Neill
Journal:  Oral Dis       Date:  1997-05       Impact factor: 3.511

7.  Genotypic differences of Candida albicans and C. dubliniensis isolates related to ethnic/racial differences within the same geographic area.

Authors:  Michael J McCullough; Jacks J Jorge; Flavio Lejbkowicz; Eli Lefler; Faris Nassar; Karl V Clemons; David A Stevens
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

8.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

9.  Rapid identification of yeast species using three primers in a polymerase chain reaction.

Authors:  J W Fell
Journal:  Mol Mar Biol Biotechnol       Date:  1993-06

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  12 in total

Review 1.  Multilocus sequence typing of pathogenic Candida species.

Authors:  Frank C Odds; Mette D Jacobsen
Journal:  Eukaryot Cell       Date:  2008-05-02

2.  Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.

Authors:  M Fleischhacker; J Pasligh; G Moran; M Ruhnke
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

Review 3.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

4.  In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.

Authors:  Arjuna Nishantha Bandara Ellepola; Ranil Samantha Dassanayake; Ziauddin Khan
Journal:  Med Princ Pract       Date:  2019-06-28       Impact factor: 1.927

5.  Oral candidosis in lichen planus: the diagnostic approach is of major therapeutic importance.

Authors:  C Kragelund; L Kieffer-Kristensen; J Reibel; E P Bennett
Journal:  Clin Oral Investig       Date:  2012-06-15       Impact factor: 3.573

6.  High-throughput identification and quantification of Candida species using high resolution derivative melt analysis of panfungal amplicons.

Authors:  Tasneem Mandviwala; Rupali Shinde; Apoorv Kalra; Jack D Sobel; Robert A Akins
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

7.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

8.  Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.

Authors:  Martine Florent; Thierry Noël; Gwenaël Ruprich-Robert; Bruno Da Silva; Valérie Fitton-Ouhabi; Christiane Chastin; Nicolas Papon; Florence Chapeland-Leclerc
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

9.  Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.

Authors:  Brenda A McManus; David C Coleman; Gary Moran; Emmanuelle Pinjon; Dorothée Diogo; Marie-Elisabeth Bougnoux; Silvia Borecká-Melkusova; Helena Bujdákova; Philip Murphy; Christophe d'Enfert; Derek J Sullivan
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

10.  In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species.

Authors:  Arjuna N B Ellepola; Rachel Chandy; Zia U Khan
Journal:  Med Princ Pract       Date:  2016-04-23       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.